60 participants
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2026-08-26
- Completion:
- 2030-04-26
Conditions
- Small Cell Lung Cancer
- Large Cell Neuroendocrine Lung Carcinoma
- Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology
- Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Interventions
- DRUG
No Results Yet